Imo: SA Health Releases More Details Of Health Webinar
More details of the recently announced Webinar event titled ‘Health Education In Times Of Crisis’ which is hosted by The…
Nigeria’s Coronavirus Infections Surpass 57, 000
Nigeria recorded 189 new coronavirus infections on Saturday, bringing the total number of cases in the country to 57,145. However,…
WHO Warns Of ‘Alarming’ COVID-19 Spread In Europe
The World Health Organisation on Thursday warned of “alarming rates of transmission” of Covid-19 across Europe and cautioned against shortening…
Moderna Shares COVID-19 Vaccine Trial Blueprints
US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19 vaccine, has…
FMC Lokoja Health Workers Suspend Strike
Health workers under the aegis of the Joint Action Congress, Federal Medical Centre, Lokoja, Friday suspended their two months’ industrial…
COVID-19 Death Toll Hits 1,091 In Nigeria
The Nigeria Centre for Disease Control (NCDC) has confirmed that the coronavirus death toll in Nigeria has jumped to 1,091.…
Indian Hospitals Scramble For Oxygen As COVID-19 Cases Increase
India’s COVID-19 cases surpassed the 5 million mark on Wednesday, with hospitals scrambling for oxygen that they need to treat…
Nigeria Is Winning Fight Against COVID-19 – PTF
Mr Boss Mustapha, the Secretary to the Government of the Federation (SGF)/Chairman of the Presidential Task Force (PTF) on COVID-19,…
China’s Four COVID-19 Vaccines Ready By November
China said its four COVID-19 vaccines may be ready for use by the public as early as November. An official…
Austria Experiencing Second Virus Wave
Austria is experiencing the start of a second wave of coronavirus infections, its chancellor said Sunday, as cases spike upwards…
COVID-19: Nigeria’s Reference Lab To Provide Capacity For Africa
The National Reference Laboratory (NRL), has been selected as one of 12 laboratories in Africa that will provide genomic sequencing…
AstraZeneca, Oxford University Resume COVID-19 Vaccine Trials
Clinical trials of a potential COVID-19 vaccine developed by AstraZeneca and the University of Oxford have resumed after a six-day…